Professor Ruth Arnon is the inventor of the new synthetic influenza vaccine and head of BiondVax’s Scientific Advisory Board. Formerly Vice-President of the Weizmann Institute of Science (1988-1997), Professor Arnon is an internationally acclaimed immunologist. Along with Prof. Michael Sela, she conceptualized and developed Copaxone®, a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration and is presently marketed worldwide.
Prior to her appointment as Vice-President, Prof. Arnon served as Head of the Department of Chemical Immunology and as Dean of the Faculty of Biology. From 1985 to 1994, Prof. Arnon was Director of the Institute’s McArthur Center for Molecular Biology of Tropical Diseases. Prof. Arnon has made significant contributions in the fields of vaccine development, cancer research and to the study of parasitic diseases.
She has served as President of the European Federation of Immunological Societies (EFIS), and as Secretary-General of the International Union of Immunological Societies (IUIS). Dr. Arnon is the recipient of numerous international and Israeli awards including the prestigious Israel Prize. Prof. Arnon is also the Advisor for Science to the President of Israel and a member of the Israel Academy of Sciences, where she presently chairs its Science Division. Prof. Arnon is the incumbent of the Paul Ehrlich Chair in Immunochemistry at the Weizmann Institute.
Professor Michel Revel, Professor of Biochemistry and Molecular Genetics at the Weizmann Institute of Science is well known for his contributions to the field of immunology. Prof. Revel’s research on Interferon, its mechanisms of action and the isolation of the human Interferon-beta gene, have led to the biotechnological development of Interferon-beta and its application in medicine. Revel also discovered the human gene for the cytokine Interleukin-6 which was developed at his laboratory and at InterPharm-Serono based on its activity for protecting nerve cells and the nerve myelin coating.
Alongside his research and development activity, Revel is deeply involved in the ethics of science and biotechnology, and serves as chairman of the Bioethics Advisory Committee of the Israel Academy of Sciences and as a member of the International Bioethics Committee of UNESCO. He integrates his work in science with traditional Judaism and Jewish philosophy in addressing bioethical issues such as use of human Embryo Stem cells, genetic intervention in man and cloning.
Prof. Revel was the recipient of the Israel Prize for medical research and the Michael Landau Prize for biotechnology. Since its establishment, he has been a member of Israel’s National Committee for Biotechnology, serving for three years as its chairman.
Professor Shai Ashkenazi is a clinical and regulatory vaccine expert, with significant contributions to flu and other infectious disease vaccine research and development. He has served on the clinical trial advisory boards for the development of a pediatric flu vaccine, vaccines for enteric infections, as well as other infectious diseases.
Prof. Ashkenazi has a deep understanding and experience with BiondVax’s universal flu vaccine as he served as the head of the data and safety monitoring board (DSMB) in all of the company’s clinical trials in Israel and abroad.
Prof Ashkenazi completed his medical education and residency in pediatrics in Israel and a fellowship in pediatric infectious diseases in Houston, Texas, USA (1987-90). He is currently Professor of Pediatrics and Incumbent of the Lea and Arieh Pickel Chair for Pediatric Research at the Sackler Faculty of Medicine, Tel Aviv University; Chairman of the Department of Pediatrics A at Schneider Children’s Medical Center; Head of the Research Laboratory for Pediatric Infectious Disease at the Felsenstein Medical Research Center, Chairman of the Israeli Scientific Council, member of the Education Committee of the World Society for Pediatric Infectious Diseases, and member of the National Council for Child Health.
Ashkenazi is a member of the Editorial Boards of several national and international medical journals, a co-author of over 200 medical publications and over 30 chapters in books and the Editor of the Hebrew Textbook of Pediatrics (8 editions). He has received dozens of research grants, including from the NIH (USA), European Union, Chief Scientist and the BSF.